Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9692930rdf:typepubmed:Citationlld:pubmed
pubmed-article:9692930lifeskim:mentionsumls-concept:C0019944lld:lifeskim
pubmed-article:9692930lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:9692930lifeskim:mentionsumls-concept:C0038727lld:lifeskim
pubmed-article:9692930lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:9692930pubmed:issue1lld:pubmed
pubmed-article:9692930pubmed:dateCreated1998-8-24lld:pubmed
pubmed-article:9692930pubmed:abstractTextA sulfatide, O-fatty-acylated 3-sulfogalactosylceramide at C6-O on galactoside, was isolated from equine brain and the chemical structure was characterized by proton NMR and MS. The O-acylation site of the acylated sulfatide was determined by the down-field shift of protons attached to a carbon having an O-acyl group in the NMR spectrum and by analysis of a partially methylated derivative before and after acetalization of the intact sulfatide using GC-MS. The O-acyl chain length was determined by GLC, revealing that it exclusively had palmitoyl and stearoyl residues as the major fatty acids. The enzymatic conversion to the O-acyl sulfatide was further examined using equine brain microsomes as an enzyme source and different lipid substrates, resulting in O-acylation of 3-sulfogalactosylceramide from stearoyl CoA, while 6-O-acyl galactosylceramide was not O-sulfated from phosphoadenosine phosphosulfate. The results were supported by the comparably different N-linked fatty acid components between two lipid substrates, in which the component of 6-O-acyl sulfatide was mostly similar to that of sulfatide, but not to 6-O-acyl galactosylceramide.lld:pubmed
pubmed-article:9692930pubmed:languageenglld:pubmed
pubmed-article:9692930pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9692930pubmed:citationSubsetIMlld:pubmed
pubmed-article:9692930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9692930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9692930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9692930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9692930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9692930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9692930pubmed:statusMEDLINElld:pubmed
pubmed-article:9692930pubmed:monthJullld:pubmed
pubmed-article:9692930pubmed:issn0014-2956lld:pubmed
pubmed-article:9692930pubmed:authorpubmed-author:KashiwagiMMlld:pubmed
pubmed-article:9692930pubmed:authorpubmed-author:MikamiTTlld:pubmed
pubmed-article:9692930pubmed:authorpubmed-author:HashiKKlld:pubmed
pubmed-article:9692930pubmed:authorpubmed-author:TsuchihashiKKlld:pubmed
pubmed-article:9692930pubmed:authorpubmed-author:AkinoTTlld:pubmed
pubmed-article:9692930pubmed:authorpubmed-author:GasaSSlld:pubmed
pubmed-article:9692930pubmed:authorpubmed-author:YachidaYYlld:pubmed
pubmed-article:9692930pubmed:authorpubmed-author:DainoTTlld:pubmed
pubmed-article:9692930pubmed:issnTypePrintlld:pubmed
pubmed-article:9692930pubmed:day1lld:pubmed
pubmed-article:9692930pubmed:volume255lld:pubmed
pubmed-article:9692930pubmed:ownerNLMlld:pubmed
pubmed-article:9692930pubmed:authorsCompleteYlld:pubmed
pubmed-article:9692930pubmed:pagination289-95lld:pubmed
pubmed-article:9692930pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:meshHeadingpubmed-meshheading:9692930-...lld:pubmed
pubmed-article:9692930pubmed:year1998lld:pubmed
pubmed-article:9692930pubmed:articleTitleCharacterization of a O-fatty-acylated sulfatide from equine brain.lld:pubmed
pubmed-article:9692930pubmed:affiliationDepartment of Chemistry, Sapporo Medical University School of Medicine, Japan.lld:pubmed
pubmed-article:9692930pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9692930pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed